BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 30754207)

  • 1. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.
    Zhang JH; Panicker LM; Seigneur EM; Lin L; House CD; Morgan W; Chen WC; Mehta H; Haj-Ali M; Yu ZX; Simonds WF
    Cell Death Differ; 2010 Oct; 17(10):1551-65. PubMed ID: 20339377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic parathyroid carcinoma treated with radiofrequency ablation: A novel therapeutic modality.
    DasGupta R; Shetty S; Keshava SN; Gupta M; Paul MJ; Thomas N
    Australas Med J; 2014; 7(9):372-5. PubMed ID: 25324902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma associated with non‑functioning parathyroid carcinoma with Warthin's tumor of the parotid gland: A case report and brief literature review.
    Abdullah AM; Qaradakhy AJ; Saeed YA; Salih AM; Karim S; Ali OA; Hassan SH; Nasraldeen SA; Mohammed SH; Kakamad FH
    Med Int (Lond); 2023; 3(3):26. PubMed ID: 37304572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
    Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
    Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid cancer.
    McClenaghan F; Qureshi YA
    Gland Surg; 2015 Aug; 4(4):329-38. PubMed ID: 26312219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.
    Cetani F; Banti C; Pardi E; Borsari S; Viacava P; Miccoli P; Torregrossa L; Basolo F; Pelizzo MR; Rugge M; Pennelli G; Gasparri G; Papotti M; Volante M; Vignali E; Saponaro F; Marcocci C
    Endocr Connect; 2013; 2(4):186-95. PubMed ID: 24145611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid carcinoma.
    Marcocci C; Cetani F; Rubin MR; Silverberg SJ; Pinchera A; Bilezikian JP
    J Bone Miner Res; 2008 Dec; 23(12):1869-80. PubMed ID: 19016595
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the genetic basis of parathyroid carcinoma.
    Gill AJ
    Endocr Pathol; 2014 Mar; 25(1):30-4. PubMed ID: 24402736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
    Parfitt J; Harris M; Wright JM; Kalamchi S
    J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRPT2 gene analysis and the diagnosis of parathyroid carcinoma.
    Cetani F; Pardi E; Banti C; Borsari S; Ambrogini E; Vignali E; Cianferotti L; Viccica G; Pinchera A; Marcocci C
    Expert Rev Endocrinol Metab; 2008 May; 3(3):377-389. PubMed ID: 30754207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
    Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT
    Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
    Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
    N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.